Literature DB >> 23388625

Adenovirus DNA replication.

Rob C Hoeben1, Taco G Uil.   

Abstract

Adenoviruses have attracted much attention as probes to study biological processes such as DNA replication, transcription, splicing, and cellular transformation. More recently these viruses have been used as gene-transfer vectors and oncolytic agents. On the other hand, adenoviruses are notorious pathogens in people with compromised immune functions. This article will briefly summarize the basic replication strategy of adenoviruses and the key proteins involved and will deal with the new developments since 2006. In addition, we will cover the development of antivirals that interfere with human adenovirus (HAdV) replication and the impact of HAdV on human disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23388625      PMCID: PMC3578361          DOI: 10.1101/cshperspect.a013003

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  73 in total

1.  Identification of conserved residues contributing to the activities of adenovirus DNA polymerase.

Authors:  H Liu; J H Naismith; R T Hay
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  An aspartic acid residue in TPR-1, a specific region of protein-priming DNA polymerases, is required for the functional interaction with primer terminal protein.

Authors:  E Dufour; J Méndez; J M Lázaro; M de Vega; L Blanco; M Salas
Journal:  J Mol Biol       Date:  2000-12-01       Impact factor: 5.469

3.  Synthesis, metabolic stability and antiviral evaluation of various alkoxyalkyl esters of cidofovir and 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]adenine.

Authors:  Jacqueline Ruiz; James R Beadle; R Mark Buller; Jill Schreiwer; Mark N Prichard; Kathy A Keith; Kenneth C Lewis; Karl Y Hostetler
Journal:  Bioorg Med Chem       Date:  2011-03-23       Impact factor: 3.641

4.  Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001.

Authors:  Kris Paolino; Jane Sande; Evelio Perez; Brett Loechelt; Barbara Jantausch; Wendy Painter; Margaret Anderson; Tim Tippin; E Randall Lanier; Terry Fry; Roberta L DeBiasi
Journal:  J Clin Virol       Date:  2010-11-19       Impact factor: 3.168

5.  Using the whole-genome sequence to characterize and name human adenoviruses.

Authors:  Donald Seto; James Chodosh; J Rodney Brister; Morris S Jones
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

6.  Toward an integrated human adenovirus designation system that utilizes molecular and serological data and serves both clinical and fundamental virology.

Authors:  Koki Aoki; Mária Benkö; Andrew J Davison; Marcela Echavarria; Dean D Erdman; Balázs Harrach; Adriana E Kajon; David Schnurr; Göran Wadell
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

7.  Interacting fidelity defects in the replicative DNA polymerase of bacteriophage RB69.

Authors:  A Bebenek; H K Dressman; G T Carver; S Ng ; V Petrov; G Yang; W H Konigsberg; J D Karam; J W Drake
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

8.  Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis.

Authors:  Hans-Heinrich Hoffmann; Andrea Kunz; Viviana A Simon; Peter Palese; Megan L Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 11.205

Review 9.  Oncolytic adenovirus: preclinical and clinical studies in patients with human malignant gliomas.

Authors:  Hong Jiang; Candelaria Gomez-Manzano; Frederick F Lang; Ramon Alemany; Juan Fueyo
Journal:  Curr Gene Ther       Date:  2009-10       Impact factor: 4.391

10.  Directed adenovirus evolution using engineered mutator viral polymerases.

Authors:  Taco G Uil; Jort Vellinga; Jeroen de Vrij; Sanne K van den Hengel; Martijn J W E Rabelink; Steve J Cramer; Julia J M Eekels; Yavuz Ariyurek; Michiel van Galen; Rob C Hoeben
Journal:  Nucleic Acids Res       Date:  2010-12-07       Impact factor: 16.971

View more
  47 in total

Review 1.  Viral and cellular interactions during adenovirus DNA replication.

Authors:  Matthew Charman; Christin Herrmann; Matthew D Weitzman
Journal:  FEBS Lett       Date:  2019-12-17       Impact factor: 4.124

2.  Cidofovir Diphosphate Inhibits Adenovirus 5 DNA Polymerase via both Nonobligate Chain Termination and Direct Inhibition, and Polymerase Mutations Confer Cidofovir Resistance on Intact Virus.

Authors:  Jeffrey M Chamberlain; Katherine Sortino; Phiroze Sethna; Andrew Bae; Randall Lanier; Robert A Bambara; Stephen Dewhurst
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

3.  DNA polymerase from temperate phage Bam35 is endowed with processive polymerization and abasic sites translesion synthesis capacity.

Authors:  Mónica Berjón-Otero; Laurentino Villar; Miguel de Vega; Margarita Salas; Modesto Redrejo-Rodríguez
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-22       Impact factor: 11.205

4.  Bam35 Tectivirus Intraviral Interaction Map Unveils New Function and Localization of Phage ORFan Proteins.

Authors:  Mónica Berjón-Otero; Ana Lechuga; Jitender Mehla; Peter Uetz; Margarita Salas; Modesto Redrejo-Rodríguez
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

Review 5.  Changing faces in virology: the dutch shift from oncogenic to oncolytic viruses.

Authors:  Zineb Belcaid; Martine L M Lamfers; Victor W van Beusechem; Rob C Hoeben
Journal:  Hum Gene Ther       Date:  2014-09-17       Impact factor: 5.695

6.  Identifying Host Factors Associated with DNA Replicated During Virus Infection.

Authors:  Emigdio D Reyes; Katarzyna Kulej; Neha J Pancholi; Lisa N Akhtar; Daphne C Avgousti; Eui Tae Kim; Daniel K Bricker; Lynn A Spruce; Sarah A Koniski; Steven H Seeholzer; Stuart N Isaacs; Benjamin A Garcia; Matthew D Weitzman
Journal:  Mol Cell Proteomics       Date:  2017-10-02       Impact factor: 5.911

7.  An Adaptable Platform for Directed Evolution in Human Cells.

Authors:  Chet M Berman; Louis J Papa; Samuel J Hendel; Christopher L Moore; Patreece H Suen; Alexander F Weickhardt; Ngoc-Duc Doan; Caiden M Kumar; Taco G Uil; Vincent L Butty; Robert C Hoeben; Matthew D Shoulders
Journal:  J Am Chem Soc       Date:  2018-12-14       Impact factor: 15.419

8.  Germline mutations and blood malignancy (Review).

Authors:  Yuping Gong; Jili Deng; Xia Wu
Journal:  Oncol Rep       Date:  2020-11-11       Impact factor: 3.906

9.  Adenovirus E4-ORF3 Targets PIAS3 and Together with E1B-55K Remodels SUMO Interactions in the Nucleus and at Virus Genome Replication Domains.

Authors:  Jennifer M Higginbotham; Clodagh C O'Shea
Journal:  J Virol       Date:  2015-07-29       Impact factor: 5.103

10.  Modeling pre-existing immunity to adenovirus in rodents: immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine.

Authors:  Jin Huk Choi; Stephen C Schafer; Lihong Zhang; Terry Juelich; Alexander N Freiberg; Maria A Croyle
Journal:  Mol Pharm       Date:  2013-08-19       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.